New Drug Halts Overproduction

WashingtonRusfertide mimics a hormone that gates iron.

It replaces repeated therapeutic bleeding with a weekly injection instead.

Unlike cytotoxic therapy, the new drug starves bone marrow of iron instead of directly killing blood cells.

Japan’s Takeda, which will sell the drug under the brand Mimrylo, has not disclosed a price.

Sources: STAT